HB 2645 creates a tax credit for qualifying doctors practicing medicine in rural Oklahoma, directly affecting licensed physicians who meet specific residency and education criteria. The credit, capped at $20,000 per year per doctor, applies to taxable income from medical practice in designated rural areas (population under 25,000 and at least 25 miles from larger cities). The bill includes an annual $1 million total credit limit, with adjustments to prevent exceeding this cap. The bill was pocket-vetoed by the governor on June 15, 2025, and never became law.
SB 1030, the "340B Drug Pricing Nondiscrimination Act," prohibits health insurers, pharmacy benefits managers, and third-party payors from discriminating against Oklahoma's 340B drug program participants. It requires equal reimbursement rates for 340B drugs compared to non-340B drugs and bans special fees, billing requirements, or restrictions solely because a provider participates in the federal 340B program. The bill also prevents interference with patients' choice to receive 340B drugs at participating pharmacies and prohibits requiring special billing modifiers for 340B claims unless mandated by federal programs. This directly affects hospitals, clinics, and pharmacies enrolled in the federal 340B program, as well as insurers and pharmacy benefit managers handling their claims.
SB 958 requires health professionals to allow parents or legal guardians to be present during minors' medical appointments and provide them copies of medical records (with an exception for suspected child abuse cases). It modifies Oklahoma's physician-patient privilege law (12 O.S. 2503) to clarify that minors under 18 cannot block parental access to their health information. The bill also updates counselor confidentiality rules (59 O.S. 1910) to require parental consent for minors under 18 to access certain services. This applies to all health services provided to minors under 18 in Oklahoma, directly affecting parents/guardians and healthcare providers.
HB 1416 requires insurers offering group health plans for state employees to ensure non-opioid pain medications (approved by the FDA) are not disadvantaged in coverage compared to opioids on their preferred drug lists. It directly affects state employee health insurance plans by mandating equal treatment for FDA-approved non-opioid pain drugs, such as those that don’t act on opioid receptors. The bill does not ban opioids or require non-opioid use but prohibits insurers from making non-opioid options harder to access through coverage rules. This applies to all drugs covered under state employee plans and takes effect November 1, 2025.
SB 438 prevents health insurance companies and health plans in Oklahoma from requiring providers (like doctors, hospitals, or clinics) to accept only credit card payments for services. It mandates that insurers must notify providers about any fees tied to payment methods and provide clear instructions for choosing alternatives like electronic transfers. The bill also prohibits charging fees for standard electronic payments (ACH) without provider consent and voids any contract clauses that try to bypass these rules. These changes directly affect health insurers, health plans, and healthcare providers across Oklahoma, taking effect November 1, 2025.
SB 427 requires all Oklahoma hospitals, medical facilities, and long-term care facilities (licensed by the State Department of Health) to publish their full policies and procedures on their public websites, keeping them updated. It also grants patients (or their legal guardians for minors or incapacitated patients) the right to request detailed records of any changes made to their medical records. The State Health Commissioner must create rules to implement these requirements, and the law takes effect on November 1, 2025. This bill directly affects health care providers by increasing transparency and gives patients greater access to their medical record history.
SB 95 updates key definitions in Oklahoma's workers' compensation law to clarify eligibility and claims processing. It directly affects injured workers (claimants), employers, insurance carriers, and medical providers by defining terms like "case manager" (requiring specific nursing licenses or certifications) and "carrier" (explicitly including self-insured employers). The bill also clarifies what constitutes a "compensable injury," excluding age-related conditions like arthritis and adding drug testing rules for claims involving intoxication. These changes aim to standardize claims administration and reduce disputes over coverage. The bill became effective after the governor signed it on May 6, 2025.
HB 1344 allows doctors to prescribe medications for uses not approved by the FDA (off-label) after obtaining a patient's informed consent, without requiring prior test results or exposure to the condition. It requires prescribers to explain treatment options, risks, and benefits to patients or their representatives before issuing such prescriptions. Pharmacists and hospitals must dispense off-label drugs unless they have a documented moral, ethical, religious objection or a life-threatening allergy history, and providers are protected from liability if they document scientific objections to specific dosages. The bill directly affects patients, doctors, pharmacists, and hospitals by clarifying dispensing rules, reducing administrative barriers, and providing legal safeguards for off-label prescribing.
HB 2065 requires Oklahoma Medicaid to reimburse healthcare providers for multiplex respiratory PCR testing (using CPT codes 87636 and 87637) when testing symptomatic patients in emergency rooms or urgent care settings. This bill directly affects hospitals and clinics participating in Oklahoma Medicaid by mandating coverage for tests that detect multiple respiratory viruses simultaneously, including COVID-19, influenza A/B, and RSV. The reimbursement applies to tests aligned with clinical best practices for diagnosing acute respiratory illnesses. The bill takes effect on November 1, 2025.
SB 1328 modifies Oklahoma's Parents' Bill of Rights and medical treatment laws to strengthen parental involvement in minors' healthcare. It removes a prohibition on requiring healthcare providers to notify parents when a minor receives treatment for pregnancy, sexually transmitted infections, drug abuse, or alcohol abuse - unless the minor is confirmed not to have these conditions. The bill clarifies that parents generally retain rights to access medical records and make healthcare decisions for their children, with limited exceptions (e.g., if a parent is under criminal investigation for abuse or in emergency situations). It directly affects parents, legal guardians, healthcare providers, and schools by changing notification requirements for specific medical services. The law aims to ensure parental awareness in minors' health care while maintaining existing emergency and confidentiality exceptions.
